Plby Group Inc
Change company Symbol lookup
Select an option...
PLBY Plby Group Inc
SVFA SVF Investment Corp
ROIUF Route1 Inc
MPB Mid Penn Bancorp Inc
NWSA News Corp
BAC Bank of America Corp
BA Boeing Co
EGRNF China Evergrande Group
SHYF Shyft Group Inc
NGS Natural Gas Services Group Inc
Go

Consumer Discretionary : Textiles, Apparel & Luxury Goods | Small Cap Growth
Company profile

PLBY Group, Inc., formerly Mountain Crest Acquisition Corp, is a leisure lifestyle company and owner of Playboy brand. The Company is principally engaged in connecting consumers around the world with products, services, and experiences. It has three reportable segments: Licensing, which includes licensing of Playboy brands to third parties; Direct-to-Consumer, including sales of third-party products through its owned-and-operated ecommerce platforms; and Digital Subscriptions and Content, including the sale of subscriptions to Playboy programming and trademark licensing for online gaming products. The Company's products are classified under four market categories: Sexual Wellness, including intimacy products and lingerie; Style and Apparel, including a variety of apparel and accessories products for men and women; Gaming and Lifestyle, such as digital gaming, hospitality and spirits; and, Beauty and Grooming, including fragrance, skincare, grooming and cosmetics for women and men.

Closing Price
$22.94
Day's Change
0.06 (0.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
23.50
Day's Low
22.71
Volume
(Heavy Day)
Volume:
1,909,836

10-day average volume:
792,802
1,909,836

U.S. Education Department opens civil-rights probe of school face-mask bans in latest clash between Republican governors and Biden administration

2:47 pm ET August 31, 2021 (MarketWatch)
Print

Ciara Linnane

Study finds Moderna vaccine produces more than double the antibodies of Pfizer and BioNTech one

The U.S. Education Department has opened civil-rights investigations of five states that have banned school districts from mandating face masks for their unvaccinated children as they return to school in person, in the latest clash between Republican governors and the administration of President Joe Biden.

Letters have been set to education officials in Iowa, South Carolina, Utah, Oklahoma and Tennessee, all of which are seeking to bar local school districts from requiring students to wear masks, the Washington Post reported The letters allege that those measures discriminate against students with disabilities, who are at greater risk of severe illness if they contract the coronavirus that causes COVID-19.

The move does not, for now, include Florida, where Gov. Ron DeSantis has pushed ahead with his threat to cut funding to schools that attempt to enforce mandates, as news site Orlando.com reported It also does not include Texas, Arkansas or Arizona, which have also sought bans. That's because those policies are not being enforced based on court orders or other state actions, the Post reported.

Biden has promised to use the Education Department to intervene as the highly transmissible delta variant of the virus SARS-CoV-2 continues to spread across the U.S. and as hospitalizations and deaths climb back to levels last seen in the winter months.

See also: With more than 150,000 Americans contracting COVID-19 per day, the price for going unvaccinated is growing

For now, the vaccine program is not open to children below the age of 12 as the Food and Drug Administration awaits the data needed to include that age group. Hospitals in states with high levels of unvaccinated people have been consistently reporting that patients are getting younger and that many require ventilators and other interventions.

The Centers for Disease Control and Prevention has said that face masks are one of the most effective ways to prevent the spread of the virus.

The U.S. seven-day average of new cases stood at 158,946 on Monday, according to a New York Times tracker, up 12% from two weeks ago. Hospitalizations stood at 100,663, trending above 100,000 for the first time since winter, while deaths are averaging 1,348 a day, trending above 1,000 a day for the first time since March.

See:WHO warns of possible 236,000 new COVID-19 deaths in Europe by December, and Fauci says U.S. could see another 100,000

The CDC's vaccine tracker is showing that 173.8 million Americans are fully vaccinated, equal to 52.4% of the overall population. That means they have had two shots of the two-dose vaccines developed by Pfizer (PFE) with German partner BioNTech (BNTX) or Moderna (MRNA), or one shot of Johnson & Johnson's (JNJ) single-dose regimen.

Some 61.7% of Americans have had at least one dose. Among adults 18 years and older, 63.4% are fully inoculated, while 74.1% have had at least one dose.

Read: Gen Z students overwhelmingly support strict COVID-19 policies as they return to school

A study comparing individual immune responses to two major COVID-19 vaccines found that Moderna's created more than double the antibodies than that of Pfizer and BioNTech. The study involving 2,499 Belgian healthcare workers who were vaccinated with two doses of either company's vaccine was published on Monday in the Journal of the American Medical Association

The study suggested a couple of reasons for the antibody level differences between vaccines, including a longer interval between shots for Moderna's vaccine -- four weeks -- compared with Pfizer's three weeks. The researchers said the Moderna shot had a higher concentration of the key active ingredient used in both vaccines.

Read: WHO warns of possible 236,000 new COVID-19 deaths in Europe by December, and Fauci says U.S. could see another 100,000

Elsewhere, the European Union said that 70% of its adult population is now fully vaccinated, meeting a goal set at the beginning of the year. However, rates vary widely among member countries, with the trading bloc's poorer countries, mostly in Eastern Europe, behind the curve.

Israel set a fresh record for daily new cases at almost 11,000, the Times of Israel reported, as testing ramps up ahead of the return to school. Israel counted 10,900 new cases on Monday, and more of those testing positive were children.

Canada was added to the U.S. State Department "do not travel" list as it struggles with COVID-19, Reuters reported The department and the CDC also warned against travel to Switzerland because of rising cases there.

Japan's health minister, Norihisa Tamura, said foreign matter found on Moderna COVID vaccine needles occurred when the needles were stuck into vials, Reuters reported separately. The ministry said over the weekend that needles may have been incorrectly inserted into vials, breaking off bits of vials' rubber stoppers.

"Whatever the reason [for the foreign matter identified] we have heard that there is no safety or other issues," Tamura told reporters. "We will continue to gather information and report back," he added.

See also: Doctors question the optics and the scientific rationale behind the plan for COVID-19 booster shots in the U.S

Latest tallies

The global tally of the coronavirus-borne illness climbed above 217.4 million on Tuesday, while the worldwide death toll rose to 4.51 million, according to data aggregated by Johns Hopkins University.

The U.S. leads the world with a total of 39 million cases and 639,271 deaths.

India has the second highest death toll after the U.S. at 438,560 and is third by cases at 32.8 million, the Johns Hopkins data show.

Brazil has second highest death toll at 579,574 and has 20.8 million cases. In Europe, Russia has 180,009 deaths, followed by the U.K. with 132,808.

China, where the virus was first discovered late in 2019, has had 107,054 confirmed cases and 4,848 deaths, according to its official numbers, which are widely held to be massively underreported.

-Ciara Linnane

	

(END) Dow Jones Newswires

August 31, 2021 14:47 ET (18:47 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.